Professor of Medicine
Baylor College of Medicine
Houston, TX, United States
Dr. Sekhar is an Endocrinologist who is interested in understanding the mechanistic origins of cognitive decline in aging, Alzheimer's disease, healthy aging, diabetes, infection and more. His expertise is in energy metabolism, nutrient metabolism and redox biology, and his research is focused on understanding and finding solutions for mitochondrial dysfunction, oxidative stress, glutathione deficiency, inflammation, insulin resistance, endothelial dysfunction and genomic damage and how these defects combine to result in cognitive decline and other health-related abnormalities in humans. His research approach is translational, linking the bench to the bedside in a quest for answers. Dr. Sekhar's research led to the discovery of GlyNAC, a unique combination of nutritional supplements, which has been validated in multiple rodent studies and human trials (including a NIH-funded randomized clinical trial) to improve multiple components of cellular health which decline in aging, and reverse multiple aging hallmarks. His translational studies with GlyNAC in rodents and humans showed reversal of mechanistic defects to improve cognition, strength and healthy aging. Dr. Sekhar is currently leading ongoing NIH-funded randomized clinical trials evaluating the impact of GlyNAC in Alzheimer's disease.
Dr. Sekhar received his medical training in India, and completed a clinical fellowship training in Endocrinology and Metabolism, and research training in Nutrient and Energy Metabolism. He is currently Professor of Medicine at Baylor College of Medicine.
Disclosure(s): No financial relationships to disclose
Dementia Prevention 2024 Session I 9564
Saturday, November 2, 2024
8:15 AM – 9:15 AM
Saturday, November 2, 2024
10:30 AM – 11:30 AM